Researchers are excited about this new drug, a groundbreaking dual agonist showing promising data in initial trials for weight loss . It acts by impacting several hormones : GLP-1 and GIP, that , when https://gregoryfmyd313091.blogvivi.com/41363937/the-new-prospect-for-body-reduction